ライフサイエンスコーパス: therapeutic approaches

1 erstanding of pathogenic pathways in AKI may identify novel therapeutic approaches.

2 ted by restoration of lung chitinase activity by genetic or therapeutic approaches.

3 quired to refine and update standardized and evidence-based therapeutic approaches.

4 the mechanisms that result in LSC survival and develop new therapeutic approaches.

5 nimal models to study disease mechanisms and to develop new therapeutic approaches.

6 in the origins of pancreatic diseases and may suggest novel therapeutic approaches.

7 underlying disease mechanisms as well as for testing novel therapeutic approaches.

8 this valuable model has been widely used for testing novel therapeutic approaches.

9 knowledge on asthma pathogenesis and the development of new therapeutic approaches.

10 lation in heart disease will open new avenues for potential therapeutic approaches against arrhythmias.

11 ization of PCSK9's proteolytic function, which could inform therapeutic approaches against its hypercholesterolemic effec

12 ted therapies, these findings also open the opportunity for therapeutic approaches aimed at limiting tumour heterogeneity

13 olved in platelet aggregation and is a validated target for therapeutic approaches and diagnostic imaging.

14 Purpose Clinical characteristics, therapeutic approaches, and prognosis of late relapse (LR) in

15 to BRAF or MEK inhibitors is probably inevitable, and novel therapeutic approaches are needed to target dormant tumors.

16 The participants debated how to determine appropriate therapeutic approaches based on disease pathophysiology and s

17 These findings suggest new therapeutic approaches for alpha-synuclein induced neurodegen

18 community to assist in the discovery and translation of new therapeutic approaches for cancer.

19 Inhibition of metabolic pathways provides novel therapeutic approaches for KS tumors.

20 These structural studies could inform antibody-based therapeutic approaches for limiting the effects of IgG-mediat

21 ing subclones, which seed metastatic sites, might offer new therapeutic approaches for limiting tumour recurrence.

22 tant implications for organismal health and could offer new therapeutic approaches for neurodegenerative diseases and oth

23 he pathogenesis of skeletal disorders and suggest potential therapeutic approaches for the treatment of LSDs.

24 levels/activity may offer a novel opportunity for designing therapeutic approaches for these diseases.

25 d provide biomarkers for those whose tumors respond and new therapeutic approaches for those whose tumors do not.

26 ems have the potential to revolutionize both preventive and therapeutic approaches for treating cardiovascular disease.

27 ment, which could lead to the development of more efficient therapeutic approaches for treating DMD patients.

28 Several of these new markers, molecular targets, and therapeutic approaches have been validated and translated int

29 d in the endosomal sorting of PC1 and PC2 could lead to new therapeutic approaches in ADPKD.

30 These data may provide important guidance to therapeutic approaches in the HIV cure agenda.

31 While most therapeutic approaches involve potentially toxic immunosuppre

32 An alternative to disease-centric therapeutic approaches is that of 'geroscience', which aims t

33 le mechanism that can potentially be exploited for combined therapeutic approaches of embolotherapy and autophagy inhibit

34 e aggregation of data from clinical trials across different therapeutic approaches play an important role in clinical dec

35 Therapeutic approaches that increase KLF2 in the carotid bodi

36 Therapeutic approaches that target aging processes may be ben

37 threat of viral epidemics and pandemics dictates a need for therapeutic approaches that target viral pathology irrespecti

38 Among the anti-Abeta therapeutic approaches, the most extensively developed is imm

39 for engraftment in experimental animals, and development of therapeutic approaches to activate innate reparative response

40 between granulocytes and endothelial cells may lead to new therapeutic approaches to improve blood vessel regeneration a

41 tors that contribute to the initiation of inflammation; and therapeutic approaches to modulate inflammation in the contex

42 This new nonhuman primate model will advance vaccine and therapeutic approaches to prevent and treat human disease cau

43 control of metastatic dissemination, and present potential therapeutic approaches to prevent or target metastatic diseas

44 egy to suppress alpha-syn aggregation and suggest potential therapeutic approaches to prevent or treat PD and related dis

45 Therapeutic approaches to the disease began in the 18th centu

46 p-associated neurodegenerative diseases and point to future therapeutic approaches to treat these disorders.

47 ction of PNN components in memory processes may lead to new therapeutic approaches to treating addiction.

48 Second, it suggests therapeutic approaches to treatment signal transduction inhib

49 mechanisms underlying IgE-mediated food allergies and novel therapeutic approaches under investigation for both the preve

50 low-molecular-weight PSMA ligands for both PET imaging and therapeutic approaches, with a focus on agents that have been